US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 21.270
  • -0.190-0.89%
Close Dec 20 16:00 ET
  • 21.270
  • 0.0000.00%
Post 20:01 ET
2.54BMarket Cap18.03P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Catalyst Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
123.42M
128.70M
+5.27M
Beat Est.
+20.19%
+25.33%
+4.27%
EPS
0.30
0.35
+0.05
Beat Est.
+204.86%
+220.69%
+15.13%
Strong Buy

Dec 22, 2024

Catalyst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 128.579M --
-- 2024/Q4 -- / 134.124M --
Nov 6, 2024 2024/Q3 128.695M / 123.421M --
Aug 7, 2024 2024/Q2 122.710M / 111.867M --
May 8, 2024 2024/Q1 98.509M / 98.775M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 128.579M--
--2024/Q4-- / 134.124M--
Nov 6, 20242024/Q3128.695M / 123.421M--
Aug 7, 20242024/Q2122.710M / 111.867M--
May 8, 20242024/Q198.509M / 98.775M--

Unlock Free Earnings Estimates

Catalyst Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data